EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation

Katelyn N Rudzik iD, Kristine S Schonder, Abhinav Humar, Heather J Johnson

Clinical Transplantation · 2024

DOI: 10.1111/ctr.15402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Transplantation, 2024. Verfasst von Katelyn N Rudzik und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Liver Transplantation, Everolimus, Living Donors, Graft Rejection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Early conversion to Everolimus (EVR) post deceased donor liver transplant has been associated with improved renal function but increased rejection. Early EVR conversion has not been evaluated after living donor liver transplant (LDLT). A retrospective cohort study was conducted to compare the rate of rejection and renal function in patients converted to EVR early post‐LDLT to patients on calcineurin inhibitors (CNIs).

Methods

This was a single center retrospective cohort study of adult LDLT recipients between January 2012 and July 2019. Patients converted to EVR within 180 days of transplant were compared to patients on CNIs. The primary endpoint was biopsy proven acute rejection (BPAR) at 24 months posttransplant. Key secondary endpoints included eGFR at 24 months, change in eGFR, adverse events, and all‐cause mortality.

Results

From a total of 173 patients involved in the study: 58 were included in the EVR group and 115 in the CNI group. Median conversion to EVR was 26 days post‐LDLT. At 24 months, there was no difference in BPAR (22.7% EVR vs. 19.1% CNI, p = 0.63). Median eGFR at 24 months posttransplant was not significantly different (68.6 [24.8 to 112.4] mL/min EVR vs. 75.9 [35.6–116.2] mL/min CNI, p = 0.103). Change in eGFR from baseline was worse in the EVR group (−13.0 [−39.9 to 13.9] mL/min EVR vs. −5.0 [−31.2 to 21.2] mL/min CNI, p = 0.047). Median change from conversion to 24 months posttransplant (EVR group only) was −3.43 mL/min/1.73 m 2 (−21.0 to 9.6).

Conclusions

Early EVR conversion was not associated with increased risk of rejection among LDLT recipients. Renal function was not impacted. EVR may be considered as an alternative after LDLT in patients intolerant of CNIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationEverolimusLiving DonorsGraft RejectionImmunosuppressive AgentsGraft SurvivalHumansFemaleMaleRetrospective StudiesMiddle AgedFollow-Up StudiesPrognosisRisk FactorsPostoperative ComplicationsAdultGlomerular Filtration RateSurvival RateKidney Function TestsCalcineurin Inhibitors

Stichwörter der Autor:innen

Everolimusliving donor liver transplantrenal functionretrospective cohort study

Substanzen

EverolimusImmunosuppressive AgentsCalcineurin Inhibitors

Autor:innen und Institutionen

  • Department of Pharmacy, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Pharmacy and Therapeutics, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
  • Thomas Starzl Transplantation Institute, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

ORCID-Profile: Katelyn N Rudzik

Zitieren

APA

Rudzik, K. N., Schonder, K. S., Humar, A., & Johnson, H. J. (2024). Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation. Clinical Transplantation. https://doi.org/10.1111/ctr.15402

Vancouver

Rudzik KN, Schonder KS, Humar A, Johnson HJ. Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation. Clinical Transplantation. 2024. doi:10.1111/ctr.15402

BibTeX
@article{Rudzik2024,
  author = {Rudzik, Katelyn N and Schonder, Kristine S and Humar, Abhinav and Johnson, Heather J},
  title = {Early Conversion to Everolimus Within 180 Days of Living Donor Liver Transplantation},
  journal = {Clinical Transplantation},
  year = {2024},
  doi = {10.1111/ctr.15402}
}
Kostenlos starten →